Alejandro Fernández-Cabrera

5PUBLICATIONS
36CO-AUTHORS
Infant and child healthPharmacogenomicsCellular nervous systemGene and molecular therapyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 23, 2026
Effectiveness and tolerability of fenfluramine in pediatric and adult patients with developmental and epileptic encephalopathies: A multicenter, retrospective, real-world clinical-practice study.

|Mar 27, 2026
Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real-world clinical practice.

Álvaro Sánchez-Guijo Benavente, Guillermina García Martín, Estuardo Daniel Castro Ruiz

|Jan 28, 2026
Freedon study: Real-life outcomes of cenobamate in different lines of treatment.

Vicente Villanueva, José María Serratosa, Alejandro Fernández-Cabrera

|Sep 15, 2025
MonoPER study: Effectiveness and tolerability of PERampanel in monotherapy in real-world after 12 months of treatment.

Alejandro Fernández-Cabrera, Paula Santamaría-Montero, Jesús García de-Soto

|Aug 14, 2025
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential.

Jesús García-de Soto, Mónica Castro-Mosquera, Jessica María Pouso-Diz

Pageof 1

Frequent Collaborators

3 joint publications

José Carlos Estévez María

2 joint publications

Pablo Cabezudo García

2 joint publications

Juan Rodriguez-Uranga

2 joint publications

Jesús García-de Soto